Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C for Postoperative Pulmonary Complications in Intracranial Tumor Surgery
NCT06421688Phase 2Not yet recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Jun 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ascorbic acid in postoperative pulmonary complications (PPC) (2 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoint: Incidence of postoperative pulmonary complications at 10 days. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
ascorbic acid
03
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT06421688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06421688.